BackMilestone Pharmaceuticals Overview

Milestone Pharmaceuticals Profit Margin

Profitability ratio analysis for MIST.

Quarterly Profit Margin

-10952.10%

As of Mar 2026

Annual Profit Margin (TTM)

-4346.42%

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin